A virtual biotech, focused on the development and commercialization of a product to treat advanced solid tumors, partnered for the development, clinical trial supply, and scale-up of a spray-drying program.
A QbD approach was used to solve a high-performance liquid chromatography analytical method problem where impurity peaks had shifting retention times, making identification and quantitation problematic.
A lead compound showed clinical promise but had limited bioavailability owing to low solubility. Learn about the challenges, including the molecular characterization and limited budget, and the structured 3-step approach.
Whether you are considering an orally disintegrating tablet to enhance pharmacokinetics through pregastric absorption, to improve patient compliance, or to gain a marketing advantage for a valued brand, Zydis® fast dissolve can help enhance the value of your investment and increase your product’s potential.
To assess the potential for oral delivery of Salmon Calcitonin, Catalent conducted a parallel screening with 2 different technologies targeting duodenal and sublingual biological barriers respectively.